Uchunguzi wa Paxlovid Boceprevir CAS 565456-77-1 ≥99.0%
Ugavi wa Kibiashara PF-07321332 Paxlovid Wapatanishi Husika na Ubora wa Juu
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Jina la Kemikali | (1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride |
Visawe | Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate Hydrochloride |
Nambari ya CAS | 565456-77-1 |
Nambari ya CAT | RF-PI318 |
Hali ya Hisa | Katika Hisa, Uzalishaji Umeongezeka Hadi Tani |
Mfumo wa Masi | C9H15NO2.ClH |
Uzito wa Masi | 205.683 |
Chapa | Ruifu Chemical |
Kipengee | Vipimo |
Mwonekano | Poda Nyeupe hadi Nyeupe |
Kitambulisho A | IR: Sawa na Dawa ya Marejeleo |
Kitambulisho B | Muda wa Kuhifadhi: Sawa na Dawa ya Marejeleo |
Enantiomer | ≤0.15% |
Uchafu Unaohusiana (na HPLC) | |
Uchafu Usiojulikana | ≤0.20% |
Jumla ya Uchafu | ≤1.0% |
Maji | ≤0.50% |
Mabaki kwenye Kuwasha | ≤0.10% |
Vyuma Vizito | ≤20ppm |
Uchambuzi | ≥99.0% |
Kiwango cha Mtihani | Kiwango cha Biashara |
Matumizi | Kati ya PF-07321332 Paxlovid (CAS 2628280-40-8) na Boceprevir (CAS 394730-60-0) |
Kifurushi: Chupa, mfuko wa karatasi ya Alumini, ngoma ya Cardboard, 25kg/Ngoma, au kulingana na mahitaji ya mteja.
Hali ya Uhifadhi:Hifadhi kwenye vyombo vilivyofungwa mahali pa baridi na kavu;Kinga dhidi ya mwanga, unyevu na kushambuliwa na wadudu.
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride (CAS 565456-77-1) ni derivative ya azabicyclohexane inayotumika katika utayarishaji wa hepatitis C. virusi (HCV) NS3 serine protease inhibitor.Ni kati ya PF-07321332 Paxlovid (CAS 2628280-40-8) na Boceprevir (CAS 394730-60-0).PF-07321332 ni kizuizi chenye nguvu na kinachofanya kazi kwa mdomo cha SARS-CoV 3C-kama protease (3CLPRO) .PF-07321332 inalenga virusi vya SARS-CoV-2 na inaweza kutumika kwa uchunguzi wa COVID-19.Boceprevir (INN, jina la biashara Victrelis) ni kizuizi cha protease kinachotumika kama matibabu ya hepatitis C genotype 1. Inashikamana na tovuti hai ya HCV nonstructural 3 NS3 (HCV).Ilikuwa ikitengenezwa na Schering-Plough, lakini sasa inatengenezwa na Merck tangu Schering iliponunuliwa mwaka wa 2009. Iliidhinishwa na FDA mnamo Mei 13, 2011.